Fact CheckerSign in

NCT06125743Recruiting

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Promoting Self-Management in Head and Neck Cancer Survivors With Lymphedema and Fibrosis [PROMISE Trial]

Source: ClinicalTrials.gov · Last updated 4 Sept 2026

Brief summary (registry, in English)

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
204 (estimated)
First submitted
1 Nov 2023
Start date
29 Mar 2024
Primary completion date
31 Aug 2027
Lead sponsor
Abramson Cancer Center at Penn Medicine
NCT number
NCT06125743

What you commit to

  • Study type: Interventional
  • Planned participants: 204
  • From 29 Mar 2024 to the primary completion date, 31 Aug 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recurrent or metastatic cancer
  • Any other active cancer
  • Acute infection
  • Acute congestive heart failure
  • Acute renal failure
  • Cardiac or pulmonary edema
  • Uncontrolled hypertension
  • Venous thrombosis

Other

  • Sensitive carotid sinus
  • Severe carotid blockage
  • Pregnant people
  • Incarcerated patients

Who the study is looking for

  • \>18 years of age
  • Post HNC primary treatment
  • No evidence of cancer (NED)
  • Completion of initial lymphedema therapy for head and neck lymphedema
  • Unable to obtain lymphedema therapy due to barriers noted above
  • History of lymphedema on the face and neck, with or without fibrosis
  • Ability to understand English in order to complete questionnaires
  • Ability to perform self-care activities for LEF management
  • Ability to provide informed consent
  • Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home
  • A valid email address

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Barbara Murphy
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.